ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

IOBT IO Biotech Inc

1,48
-0,05 (-3,27%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
IO Biotech Inc IOBT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,05 -3,27% 1,48 23:30:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,53 1,48 1,58 1,48 1,53
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202422:30GLOBEIO Biotech Announces Abstract Accepted for Presentation at..
15.4.202414:30GLOBEIO Biotech Expands Senior Leadership Team to Progress..
09.4.202418:00GLOBEIO Biotech Presents New Data at AACR 2024 Further Supporting..
05.4.202414:30GLOBEIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business..
11.3.202421:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
06.3.202422:11GLOBEIO Biotech Announces Acceptance of Abstract to be Presented..
05.3.202423:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05.3.202422:46EDGAR2Form 8-K - Current report
05.3.202422:40GLOBEIO Biotech Announces 2023 Fourth-Quarter and Year-End..
26.2.202422:05GLOBEIO Biotech to Present at 44th Annual Cowen Health Care..
08.1.202414:11EDGAR2Form 8-K - Current report
21.12.202314:30GLOBEIO Biotech Announces First Patient Dosed in Phase 2..
24.11.202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202314:12GLOBEIO Biotech Announces 2023 Third Quarter Results
13.11.202314:10EDGAR2Form 8-K - Current report
13.11.202314:00GLOBEIO Biotech Appoints Helen Collins, MD, to its Board of..
10.11.202314:00GLOBEIO Biotech Completes Enrollment of 380 Patients in Pivotal..
08.11.202322:30GLOBEIO Biotech Announces Participation in Upcoming Investor..
01.11.202313:30GLOBEIO Biotech Presents Three Posters at the Society for..
23.10.202307:00GLOBEEncouraging Preliminary Data from a Phase 2 Trial Evaluating..
03.10.202322:30GLOBEIO Biotech Announces Three Poster Presentations at the..
12.9.202322:06EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
12.9.202314:05GLOBEIO Biotech Announces New Data Related to its IO102-IO103..
11.9.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
07.9.202316:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.9.202314:35GLOBEIO Biotech Announces Participation in Upcoming Investor..
30.8.202322:16EDGAR2Form S-3 - Registration statement under Securities Act of..
16.8.202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.8.202323:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
12.8.202303:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202314:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202314:31EDGAR2Form 8-K - Current report
11.8.202314:30GLOBEIO Biotech Announces 2023 Second Quarter Results
11.8.202314:05GLOBEIO Biotech Appoints Heidi Hunter to its Board of Directors
10.8.202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202302:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202314:05GLOBEIO Biotech Announces Abstract Accepted for Poster..
07.8.202314:31EDGAR2Form 8-K - Current report
07.8.202314:30GLOBEIO Biotech, Inc. Announces $75 Million Private Placement..
28.7.202314:05GLOBEIO Biotech Announces First Patient Dosed in..
25.7.202322:05GLOBEIO Biotech Announces Abstract Accepted for Mini Oral..
19.7.202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.7.202322:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
18.7.202322:05EDGAR2Form 8-K - Current report
18.7.202322:05GLOBEIO Biotech Strengthens Executive Management and US Presence..
14.6.202314:00GLOBEIO Biotech Announces Achievement of Significant Phase 3..
01.6.202314:30GLOBEIO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock